| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.3 | 3e-07 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.29 | 4e-06 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.18 | 0.003 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.18 | 0.005 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.15 | 0.03 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.13 | 0.04 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | 0.12 | 0.08 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.058 | 0.4 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.045 | 0.5 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.034 | 0.6 |